RECURSION PHARMACEUTICALS Inc

Insiders made some notable gains last week 9-01-23

by

August ended on a low note as all three leading market indexes lost ground, with the Dow Jones Industrial Average (DJIA) falling 2.5%, the Nasdaq down 2.2%, and the S&P 500 off 1.7%. Insiders made some notable gains last week on their purchases, but since they are subject to the short-swing rule, it doesn’t really matter much to them since any short-term profits would have to be disgorged. For the most part, these insiders were bottom feeders on depressed company stock. You can be an insider, too– by clicking here   Name: James Hollingshead Position: President and CEO Transaction Date: … Read more

‘t want to go down.

by

Despite the best efforts of banking emperors like Jamie Dimon of JP Morgan or all-knowing market strategists like Mike Wilson of Morgan Stanley, this stock market refuses to go down.  Last week’s market rally has already numbed the pain from February’s losses. The bulls are stomping their hoofed feet at the fences, dying to bust out. An insomniac lies awake at night, Puzzling over a conundrum so tight; the answer eludes them, it’s out of sight, And the puzzle keeps them up till daylight. They toss and turn, and they try to sleep, But the puzzle is just too deep; … Read more

The Fed has a Hammer but needs a Scalpel Insider Buying Week 2-24-23

by

It’s a commonly held view amongst market strategists that the Fed follows interest rates, not determines them. You don’t have to look very far to see plenty of evidence of that.  It’s a quiet conspiracy amongst talking heads and futures markets that economic events and statistics are immediately reflected in real-time price action in the bond markets, dot plots, and other dynamic markets. The Fed will often talk up its view, and by the time they do take some action on rates, it’s hardly a surprise. This is, of course, by design. The Powell Fed believes in transparency and no … Read more